{"count": 8, "results": [{"_id": "33135040", "pmid": 33135040, "title": "Luteolin cooperated with metformin hydrochloride alleviates lipid metabolism disorders and optimizes intestinal flora compositions of high-fat diet mice.", "journal": "Food Funct", "authors": ["Ge X ", "Wang C ", "Chen H ", "Liu T ", "Chen L ", "Huang Y ", "Zeng F ", "Liu B "], "date": "2020-11-18T00:00:00Z", "doi": "10.1039/d0fo01840f", "meta_date_publication": "2020 Nov 18", "meta_volume": "11", "meta_issue": "11", "meta_pages": "10033-10046", "score": 50266.664, "text_hl": "@CHEMICAL_Luteolin @CHEMICAL_MESH:D047311 @@@Luteolin@@@ cooperated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin hydrochloride@@@ alleviates @<m>DISEASE_Lipid_Metabolism_Disorders</m> @DISEASE_MESH:D052439 @@@lipid metabolism disorders@@@ and optimizes intestinal flora compositions of high-fat diet @SPECIES_10090 @@@mice@@@.", "citations": {"NLM": "Ge X , Wang C , Chen H , Liu T , Chen L , Huang Y , Zeng F , Liu B . Luteolin cooperated with metformin hydrochloride alleviates lipid metabolism disorders and optimizes intestinal flora compositions of high-fat diet mice. Food Funct. 2020 Nov 18;11(11):10033-10046. PMID: 33135040", "BibTeX": "@article{33135040, title={Luteolin cooperated with metformin hydrochloride alleviates lipid metabolism disorders and optimizes intestinal flora compositions of high-fat diet mice.}, author={Ge X  and Wang C  and Chen H  and Liu T  and Chen L  and Huang Y  and Zeng F  and Liu B }, journal={Food Funct}, volume={11}, number={11}, pages={10033-10046}}"}}, {"_id": "38273354", "pmid": 38273354, "pmcid": "PMC10809441", "title": "Yam Gruel alone and in combination with metformin regulates hepatic lipid metabolism disorders in a diabetic rat model by activating the AMPK/ACC/CPT-1 pathway", "journal": "Lipids Health Dis", "authors": ["Dai Y", "Qiu C", "Zhang D", "Li M", "Liu W"], "date": "2024-01-25T00:00:00Z", "doi": "10.1186/s12944-024-02014-2", "meta_date_publication": "2024 Jan 25", "meta_volume": "23", "meta_issue": "1", "meta_pages": "28", "score": 50262.473, "text_hl": "Yam Gruel alone and in combination with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ regulates @<m>DISEASE_Lipid_Metabolism_Disorders</m> @DISEASE_MESH:D052439 @@@hepatic lipid metabolism disorders@@@ in a @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rat@@@ model by activating the @GENE_PRKAA2 @GENE_78975 @@@AMPK@@@/@GENE_ACACA @GENE_31 @@@ACC@@@/@GENE_CPT1A @GENE_1374 @@@CPT-1@@@ pathway", "citations": {"NLM": "Dai Y, Qiu C, Zhang D, Li M, Liu W. Yam Gruel alone and in combination with metformin regulates hepatic lipid metabolism disorders in a diabetic rat model by activating the AMPK/ACC/CPT-1 pathway Lipids Health Dis. 2024 Jan 25;23(1):28. PMID: 38273354", "BibTeX": "@article{38273354, title={Yam Gruel alone and in combination with metformin regulates hepatic lipid metabolism disorders in a diabetic rat model by activating the AMPK/ACC/CPT-1 pathway}, author={Dai Y and Qiu C and Zhang D and Li M and Liu W}, journal={Lipids Health Dis}, volume={23}, number={1}, pages={28}}"}}, {"_id": "40864173", "pmid": 40864173, "title": "Dual Therapy Triumph: Yuquan Capsules and Metformin in Combating Type 2 Diabetes Mellitus Disorders.", "journal": "Clin Pharmacol Drug Dev", "authors": ["Zhang L", "Fan Q", "Chen L"], "date": "2025-08-27T00:00:00Z", "doi": "10.1002/cpdd.1592", "meta_date_publication": "2025 Aug 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50261.492, "text_hl": "This study aims to evaluate the combined effects of Yuquan capsules and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Lipid_Metabolism_Disorders</m> @DISEASE_MESH:D052439 @@@glucose and lipid metabolism disorders@@@ and microinflammation in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ (@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@). ", "citations": {"NLM": "Zhang L, Fan Q, Chen L. Dual Therapy Triumph: Yuquan Capsules and Metformin in Combating Type 2 Diabetes Mellitus Disorders. Clin Pharmacol Drug Dev. 2025 Aug 27;():. PMID: 40864173", "BibTeX": "@article{40864173, title={Dual Therapy Triumph: Yuquan Capsules and Metformin in Combating Type 2 Diabetes Mellitus Disorders.}, author={Zhang L and Fan Q and Chen L}, journal={Clin Pharmacol Drug Dev}}"}}, {"_id": "40520024", "pmid": 40520024, "title": "Metformin Alleviates Liver Metabolic Dysfunction in Polycystic Ovary Syndrome by Activating the Ethe1/Keap1/PINK1 Pathway.", "journal": "Int J Biol Sci", "authors": ["Xie Y", "Tian Y", "Huang J", "Deng W", "Li X", "Liu Y", "Liu H", "Gao L", "Xie Q", "Yu Q"], "date": "2025-05-21T00:00:00Z", "doi": "10.7150/ijbs.104778", "meta_date_publication": "2025", "meta_volume": "21", "meta_issue": "8", "meta_pages": "3505-3526", "score": 50252.324, "text_hl": "Here, we investigated the potential protective effects and the underlying mechanisms of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ against @<m>DISEASE_Lipid_Metabolism_Disorders</m> @DISEASE_MESH:D052439 @@@hepatic lipid metabolic disorders@@@ in prenatal anti-Mullerian hormone (PAMH)-induced @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Xie Y, Tian Y, Huang J, Deng W, Li X, Liu Y, Liu H, Gao L, Xie Q, Yu Q. Metformin Alleviates Liver Metabolic Dysfunction in Polycystic Ovary Syndrome by Activating the Ethe1/Keap1/PINK1 Pathway. Int J Biol Sci. 2025;21(8):3505-3526. PMID: 40520024", "BibTeX": "@article{40520024, title={Metformin Alleviates Liver Metabolic Dysfunction in Polycystic Ovary Syndrome by Activating the Ethe1/Keap1/PINK1 Pathway.}, author={Xie Y and Tian Y and Huang J and Deng W and Li X and Liu Y and Liu H and Gao L and Xie Q and Yu Q}, journal={Int J Biol Sci}, volume={21}, number={8}, pages={3505-3526}}"}}, {"_id": "35704155", "pmid": 35704155, "title": "Chlorogenic acid improves anti-lipogenic activity of metformin by positive regulating of AMPK signaling in HepG2 cells.", "journal": "Cell Biochem Biophys", "authors": ["Namvarjah F", "Shokri-Afra H", "Moradi-Sardareh H", "Khorzoughi RB", "Pasalar P", "Panahi G", "Meshkani R"], "date": "2022-09-01T00:00:00Z", "doi": "10.1007/s12013-022-01077-1", "meta_date_publication": "2022 Sep", "meta_volume": "80", "meta_issue": "3", "meta_pages": "537-545", "score": 50248.797, "text_hl": "Therefore, co-administration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ with @CHEMICAL_Chlorogenic_Acid @CHEMICAL_MESH:D002726 @@@CGA@@@ may have further medical value in treating @<m>DISEASE_Lipid_Metabolism_Disorders</m> @DISEASE_MESH:D052439 @@@lipid metabolism disorders@@@.", "citations": {"NLM": "Namvarjah F, Shokri-Afra H, Moradi-Sardareh H, Khorzoughi RB, Pasalar P, Panahi G, Meshkani R. Chlorogenic acid improves anti-lipogenic activity of metformin by positive regulating of AMPK signaling in HepG2 cells. Cell Biochem Biophys. 2022 Sep;80(3):537-545. PMID: 35704155", "BibTeX": "@article{35704155, title={Chlorogenic acid improves anti-lipogenic activity of metformin by positive regulating of AMPK signaling in HepG2 cells.}, author={Namvarjah F and Shokri-Afra H and Moradi-Sardareh H and Khorzoughi RB and Pasalar P and Panahi G and Meshkani R}, journal={Cell Biochem Biophys}, volume={80}, number={3}, pages={537-545}}"}}, {"_id": "40916822", "pmid": 40916822, "title": "Effects of metformin on gut microbiota and short-/medium-chain fatty acids in high-fat diet rats.", "journal": "Zhong Nan Da Xue Xue Bao Yi Xue Ban", "authors": ["Shi Y", "Xing L", "Wu S", "Yue F", "He T", "Zhang J", "Ouyang L", "Gao S", "Zhang D", "Zhou Z"], "date": "2025-05-28T00:00:00Z", "doi": "10.11817/j.issn.1672-7347.2025.250151", "meta_date_publication": "2025 May 28", "meta_volume": "50", "meta_issue": "5", "meta_pages": "851-863", "score": 50245.535, "text_hl": "At the end of the experiment, all @SPECIES_10116 @@@rats@@@ were sacrificed, and serum, liver, and colonic contents were collected for assessment of @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ and @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ metabolism, liver pathology, gut microbiota composition, and the concentrations of short-/medium-chain fatty acids. RESULTS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ significantly improved HFD-induced @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ and @<m>DISEASE_Lipid_Metabolism_Disorders</m> @DISEASE_MESH:D052439 @@@lipid metabolic disorders@@@ and @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver injury@@@. ", "citations": {"NLM": "Shi Y, Xing L, Wu S, Yue F, He T, Zhang J, Ouyang L, Gao S, Zhang D, Zhou Z. Effects of metformin on gut microbiota and short-/medium-chain fatty acids in high-fat diet rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 May 28;50(5):851-863. PMID: 40916822", "BibTeX": "@article{40916822, title={Effects of metformin on gut microbiota and short-/medium-chain fatty acids in high-fat diet rats.}, author={Shi Y and Xing L and Wu S and Yue F and He T and Zhang J and Ouyang L and Gao S and Zhang D and Zhou Z}, journal={Zhong Nan Da Xue Xue Bao Yi Xue Ban}, volume={50}, number={5}, pages={851-863}}"}}, {"_id": "27865164", "pmid": 27865164, "title": "Metformin improves lipid metabolism disorders through reducing the expression of microsomal triglyceride transfer protein in OLETF rats.", "journal": "Diabetes Res Clin Pract", "authors": ["Wang N", "Zhang J", "Wu Y", "Liu J", "Liu L", "Guo X"], "date": "2016-12-01T00:00:00Z", "doi": "10.1016/j.diabres.2016.10.006", "meta_date_publication": "2016 Dec", "meta_volume": "122", "meta_issue": "", "meta_pages": "170-178", "score": 50066.992, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ improves @<m>DISEASE_Lipid_Metabolism_Disorders</m> @DISEASE_MESH:D052439 @@@lipid metabolism disorders@@@ through reducing the expression of @GENE_MTTP @GENE_310900 @@@microsomal triglyceride transfer protein@@@ in OLETF @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Wang N, Zhang J, Wu Y, Liu J, Liu L, Guo X. Metformin improves lipid metabolism disorders through reducing the expression of microsomal triglyceride transfer protein in OLETF rats. Diabetes Res Clin Pract. 2016 Dec;122():170-178. PMID: 27865164", "BibTeX": "@article{27865164, title={Metformin improves lipid metabolism disorders through reducing the expression of microsomal triglyceride transfer protein in OLETF rats.}, author={Wang N and Zhang J and Wu Y and Liu J and Liu L and Guo X}, journal={Diabetes Res Clin Pract}, volume={122}, pages={170-178}}"}}, {"_id": "31468388", "pmid": 31468388, "title": "Taurine Improves the Actions of Metformin and Lovastatin on Plasma Markers of Carbohydrate and Lipid Dysfunction of Diabetic Rats.", "journal": "Adv Exp Med Biol", "authors": ["Pandya K", "Lau-Cam CA"], "date": "2019-01-01T00:00:00Z", "doi": "10.1007/978-981-13-8023-5_8", "meta_date_publication": "2019", "meta_volume": "1155", "meta_issue": "", "meta_pages": "87-99", "score": 50061.0, "text_hl": "@CHEMICAL_Taurine @CHEMICAL_MESH:D013654 @@@Taurine@@@ Improves the Actions of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@Lovastatin@@@ on Plasma Markers of @CHEMICAL_Carbohydrates @CHEMICAL_MESH:D002241 @@@Carbohydrate@@@ and @<m>DISEASE_Lipid_Metabolism_Disorders</m> @DISEASE_MESH:D052439 @@@Lipid Dysfunction@@@ of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetic@@@ @SPECIES_10116 @@@Rats@@@.", "citations": {"NLM": "Pandya K, Lau-Cam CA. Taurine Improves the Actions of Metformin and Lovastatin on Plasma Markers of Carbohydrate and Lipid Dysfunction of Diabetic Rats. Adv Exp Med Biol. 2019;1155():87-99. PMID: 31468388", "BibTeX": "@article{31468388, title={Taurine Improves the Actions of Metformin and Lovastatin on Plasma Markers of Carbohydrate and Lipid Dysfunction of Diabetic Rats.}, author={Pandya K and Lau-Cam CA}, journal={Adv Exp Med Biol}, volume={1155}, pages={87-99}}"}}]}